David Ian Highton

age:

56 years

appointments:

16 active

7 prior

primary industry:

Manufacture of basic pharmaceutical products and pharmaceutical preparations

about David

Since 2017, Mr Highton has been a director of 23 companies, the current directorship have a combined turnover of approximately £1.5b.

Combined Valuation

£3.8b

Combined Turnover

£1.5b

active directorships over time

company
turnover
valuation
start
end
status
role
pfizer limited£1.2b£1.8bJun 2022-OpenDirector
pharmacia limited£32.2m£621.5mFeb 2021-OpenDirector
pfizer r&d uk limited£273.3m£527.3mJun 2022-OpenDirector
pfizer development services (uk) limited£44.8m£505.7mFeb 2021-OpenDirector
john wyeth & brother limited-£205.4mFeb 2021-OpenDirector
global blood therapeutics uk limited£1.7m£35.4mApr 2023-OpenDirector
g.d.searle & co.limited-£33mJul 2017-OpenDirector
seagen u.k. ltd.£9.5m£19.3mDec 2023-OpenDirector
reviral limited-£18.3mJun 2022-OpenDirector
reviral limited-£18.3mJun 2022-OpenDirector
pfizer specialty uk limited-£13mJul 2017-OpenDirector
pfizer consumer healthcare-£9.7mFeb 2021-OpenDirector
hospira aseptic services limited-£641.6kAug 2020-OpenDirector
mpp trustee limited-£1.9Aug 2024-OpenDirector
neusentis limited--Feb 2021-OpenDirector